TriNutra, the supplier of the first cold-pressed black seed (Nigella sativa) oil standardised to 3% thymoquinone, announces the publication of its most recent study on the benefits of ThymoQuin for improved heart health
TriNutra’s Nigella sativa seeds contain a high amount of thymoquinone, the main active within the seeds, which is a powerful antioxidant.
This non-randomised human clinical study was published in the journal Food Science & Nutrition Research, and tested the effects of the standardised black seed oil ThymoQuin, with a free fatty acid level of 1.8%, on blood pressure and heart rate in healthy individuals.
“Almost a third of the adult population in America experiences hypertension, and natural products, including Nigella sativa oil, have long been considered as a therapeutic remedy in many traditional medicine practices across the world,” said Morris Zelkha, CEO of TriNutra.
“This study demonstrated how ThymoQuin can help provide significant improvement towards healthy blood circulation measurements, which has not been seen from other more common varieties of black seed oil.”
The study followed 19 volunteers with baseline resting blood pressure measuring between SBP 135-159 and DBP 85-99 for 108 days.
All subjects were given 500 mg of ThymoQuin 3%, containing 15 mg of thymoquinone, for the first 42 days, followed by a washout period of 3 weeks, then a placebo for 6 weeks until study day 108.
During the 6-week treatment period, the subjects experienced a marked decrease of 11.2% in SBP and 12.2% DBP.
“The research supporting black seed oil supplementation for multiple facets of health continues to grow,” said Chris Holland, VP of Sales at Barrington Nutritionals.
“The results of this study add to the arsenal of more than 50 additional clinical trials demonstrating the benefits of black seed oil, it’s no wonder this powerful ingredient has been gaining increased awareness and interest during the last few years."